A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
Clinical trial NCT06732895 · RECRUITING
Trial details
- NCT number
- NCT06732895
- Sponsor
- Ascendis Pharma A/S
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-10
- Primary completion
- 2027-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.